Scientists hunt for immune clues to predict ovarian cancer survival
NCT ID NCT03862677
Summary
This study aims to discover immune system markers in the blood and tumors of ovarian cancer patients that might predict how well they respond to treatment. Researchers will collect samples from 300 patients undergoing standard surgery, chemotherapy, or immunotherapy. The goal is to find biological clues that could help doctors better understand and predict a patient's disease course, not to test a new treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EPITHELIAL OVARIAN CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Leiden University Medical Center
RECRUITINGLeiden, Netherlands
Contact
Conditions
Explore the condition pages connected to this study.